Differentiating anxiety from fear: an experimental-pharmacological approach.

Anxiety Fear Lorazepam Revised-reinforcement-sensitivity-theory

Journal

Personality neuroscience
ISSN: 2513-9886
Titre abrégé: Personal Neurosci
Pays: England
ID NLM: 101718316

Informations de publication

Date de publication:
2020
Historique:
received: 25 07 2019
revised: 13 01 2020
accepted: 22 01 2020
entrez: 30 6 2020
pubmed: 1 7 2020
medline: 1 7 2020
Statut: epublish

Résumé

Gray's theory of personality postulates that fear and anxiety are distinct emotional systems with only the latter being sensitive to anxiolytic drugs. His work was mainly based on animal research, and translational studies validating his theory are scarce. Previous work in humans showed an influence of the benzodiazepine lorazepam on both systems, however, dependent on dosage (1 and 2 mg) and personality differences in negative emotionality. The present study aims to replicate these findings, and in addition tests the drug threshold effect by introducing a lower dosage of 0.5 mg lorazepam. Fifty healthy adults (23 males, age

Identifiants

pubmed: 32596627
doi: 10.1017/pen.2020.1
pmc: PMC7303801
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e6

Informations de copyright

© The Author(s) 2020.

Références

Transl Psychiatry. 2013 Apr 16;3:e246
pubmed: 23591970
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20582-6
pubmed: 21059963
Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 Suppl:S3-14
pubmed: 2694228
J Clin Psychiatry. 1978 Oct;39(10 Pt 2):16-23
pubmed: 30762
Int J Neuropsychopharmacol. 2006 Apr;9(2):155-66
pubmed: 15896265
Br J Clin Pharmacol. 2003 Jan;55(1):39-50
pubmed: 12534639
J Psychopharmacol. 2018 Jun;32(6):678-690
pubmed: 29783905
Eur J Pharmacol. 2003 Feb 28;463(1-3):97-116
pubmed: 12600704
Emotion. 2007 May;7(2):252-61
pubmed: 17516804
Psychopharmacology (Berl). 1990;101(4):511-8
pubmed: 2388974
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
Neurosci Biobehav Rev. 2019 Mar;98:71-84
pubmed: 30611801
Brain Cogn. 2008 Dec;68(3):415-35
pubmed: 19028266
Pharmacol Biochem Behav. 1990 Apr;35(4):775-80
pubmed: 2345756
Biol Psychiatry. 2006 Oct 1;60(7):760-6
pubmed: 16631127
Behav Neurosci. 2004 Jun;118(3):462-9
pubmed: 15174923
Psychiatry Res. 2010 Aug 30;179(1):86-90
pubmed: 20478625
Personal Neurosci. 2019 Jul 31;2:e4
pubmed: 32435739
Acta Psychol (Amst). 2011 Feb;136(2):189-202
pubmed: 20507830
J Neurosci. 2009 Oct 7;29(40):12617-24
pubmed: 19812336
J Abnorm Psychol. 2009 May;118(2):335-47
pubmed: 19413408

Auteurs

Julia V Lippold (JV)

Department of Psychology, University of Bonn, Bonn, Germany.

Ulrich Ettinger (U)

Department of Psychology, University of Bonn, Bonn, Germany.

René Hurlemann (R)

Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
Department of Psychiatry, University of Oldenburg, Oldenburg, Germany.
Department of Psychiatry, University of Oldenburg Medical Campus, Bad Zwischenahn, Germany.
Division of Medical Psychology, Department of Psychiatry, University Hospital Bonn, Bonn, Germany.

Philip J Corr (PJ)

Department of Psychology, City, University of London, London, UK.

Martin Reuter (M)

Department of Psychology, University of Bonn, Bonn, Germany.
Center for Economics and Neuroscience, University of Bonn, Bonn, Germany.

Adam M Perkins (AM)

Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, UK.

Classifications MeSH